ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 61 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,000 | +14.3% | 7,459 | +370.6% | 0.00% | – |
| Q1 2024 | $7,000 | +133.3% | 1,585 | +134.8% | 0.00% | – |
| Q4 2023 | $3,000 | – | 675 | +13400.0% | 0.00% | – |
| Q3 2023 | $0 | -100.0% | 5 | -99.4% | 0.00% | – |
| Q2 2023 | $1,000 | -66.7% | 898 | -68.9% | 0.00% | – |
| Q1 2023 | $3,000 | -76.9% | 2,891 | -65.9% | 0.00% | – |
| Q4 2022 | $13,000 | +550.0% | 8,476 | +1256.2% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 625 | +116.3% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 289 | -92.0% | 0.00% | – |
| Q1 2022 | $16,000 | -54.3% | 3,618 | -24.7% | 0.00% | – |
| Q4 2021 | $35,000 | -66.7% | 4,803 | +92.8% | 0.00% | – |
| Q3 2021 | $105,000 | – | 2,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 6,398,250 | $29,176,000 | 26.83% |
| Foresite Capital Management V, LLC | 1,431,826 | $6,529,000 | 2.67% |
| Slate Path Capital LP | 3,735,000 | $17,032,000 | 0.87% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $8,834,000 | 0.86% |
| Alphabet Inc. | 5,680,785 | $25,904,000 | 0.84% |
| 683 Capital Management, LLC | 2,350,000 | $10,716,000 | 0.57% |
| Orbimed Advisors | 5,056,000 | $23,055,000 | 0.37% |
| Redmile Group, LLC | 1,920,960 | $8,760,000 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,560,000 | 0.19% |
| Triatomic Management LP | 25,800 | $118,000 | 0.10% |